Abstract
Introduction
Healthcare quality is increasingly assessed through patient-centered metrics, with Patient-Reported Experience Measures (PREMs) emerging as essential tools to evaluate the effectiveness of care models beyond clinical outcomes. In oncohematology, where treatments are prolonged and emotionally demanding, patient experience plays a critical role in therapeutic adherence and perceived safety.
Methods
This cross-sectional study was conducted at Sagunto University Hospital and included 90 patients undergoing active oncohematologic treatment. The impact of the Oncohematologic Pharmaceutical Care (OH-PC) consultation—a differentiated model integrating clinical pharmacists into direct patient care—was evaluated using a 16-item Likert survey based on validated instruments aligned with IEXPAC domains.
Results
The OH-PC model showed significant improvements compared to the traditional medication dispensing approach. Patients reported enhanced accessibility, better quality of information, and stronger professional-patient relationships. Notably, 100% of respondents stated they received clear explanations about their treatment, and over 94% expressed high satisfaction. The model positively impacted all IEXPAC domains: productive interactions (98.2%), self-management (95.1%), and relational model (90.0%).
Conclusions
The OH-PC consultation significantly improved patient-reported experience in oncohematologic care. These findings highlight the pivotal role of pharmacists in enhancing patient-centered care and suggest that the OH-PC model could be scalable to other chronic and complex care settings. The integration of PREMs is recommended for continuous quality improvement and healthcare system transformation.
Get full access to this article
View all access options for this article.